Volume 9, Number 10—October 2003
Dispatch
Severe Acute Respiratory Syndrome: Lessons from Singapore
Table 4
Patient | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
---|---|---|---|---|---|---|---|
Hemoglobin (g/dL) | 15.0 | 8.4 | 11.2 | 12.5 | 14.3 | 13.2 | 13.5 |
Leukocyte count (X10-9/L) | 3.73 | 7.2 | 4.94 | 6.3 | 3.6 | 6.2 | 6.76 |
Lymphocyte count (X10-9/L) | 0.83 | 1.34 | 1.04 | 0.30 | 0.84 | 1.13 | 0.97 |
Platelet count (X10-9/L) | 121 | 163 | 167 | 231 | 176 | 184 | 240 |
ALT (U/L) | 51 | 31 | 20 | 10 | 15 | 19 | 8 |
AST (U/L) | 68 | 52 | 19 | 21 | 21 | 21 | 25 |
CK | 35 | 192 | 73 | 68 | 85 | 88 | 56 |
LDH | 685 | 1,034 | 390 | 280 | 275 | 319 | 696 |
C-reactive protein | 3.1 | 4.3 | 0.9 | <0.7 | <0.7 | <0.7 | <0.7 |
Procalcitonin | ND | 1.27 | ND | ND | ND | ND | ND |
aALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; LDH, lactate dehydrogenase; ND, not done.
Page created: January 10, 2011
Page updated: January 10, 2011
Page reviewed: January 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.